文献速递神经MR

Wave-CAIPI磁敏感加权成像在1.5T常规脑MRI中的临床验证

Clinical validation of Wave-CAIPI susceptibility-weighted imaging for routine brain MRI at 1.5 T.
PubMed 文献 · Eur Radiol · 2022-08-04

本研究纳入172例在1.5T行脑MRI的患者,比较高度加速的Wave-SWI与常规3D SWI及2D T2*加权梯度回波序列。结果显示Wave-SWI在病变显示、信号丢失伪影及整体图像质量上优于T2*w-GRE,在正常解剖和病变显示等方面非劣效于标准SWI。

要点

  • Wave-SWI在1.5T下病变显示和整体图像质量优于T2*w-GRE。
  • Wave-SWI在正常解剖和病变显示上非劣效于标准SWI(15%界值)。
  • Wave-SWI运动伪影优于标准SWI,但图像噪声不及两种常规序列。

核心结论

  • Wave-SWI可在1.5T临床环境中稳健运行并保持诊断质量。
  • Wave-SWI在病变显示、信号丢失伪影和整体图像质量上优于T2*w-GRE。
  • Wave-SWI在正常解剖和病变显示、信号丢失伪影及整体图像质量上非劣效于标准SWI。

研究设计与样本

  • 单中心临床验证研究,纳入172例在1.5T行脑MRI的患者。
  • 每例患者均扫描一种常规磁敏感序列(标准SWI或T2*w-GRE)及高度加速Wave-SWI序列。
  • 由两名对采集技术不知情的放射科医生对图像进行评分。

关键影像表现/征象

  • Wave-SWI在病变显示、信号丢失伪影、正常解剖显示及整体图像质量上优于T2*w-GRE(均p<0.001)。
  • Wave-SWI在正常解剖和病变显示、信号丢失伪影及整体图像质量上非劣效于标准SWI(均p<0.001)。
  • Wave-SWI的运动伪影评分优于标准SWI(p<0.001)。
  • 两种常规磁敏感序列的图像噪声评分优于Wave-SWI(p<0.001)。

诊断标准与关键数值

  • 优效性检验用于比较Wave-SWI与T2*w-GRE。
  • 非劣效性检验用于比较Wave-SWI与标准SWI,界值为15%。

临床应用与阅片要点

  • Wave-SWI可用于1.5T脑MRI,在保持诊断质量的同时加速3D高分辨率磁敏感成像。
  • 需注意Wave-SWI图像噪声较常规序列更明显,阅片时应结合序列特点评估。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Wave-CAIPI (Controlled Aliasing in Parallel Imaging) enables dramatic reduction in acquisition time of 3D MRI sequences such as 3D susceptibility-weighted imaging (SWI) but has not been clinically evaluated at 1.5 T. We sought to compare highly accelerated Wave-CAIPI SWI (Wave-SWI) with two alternative standard sequences, conventional three-dimensional SWI and two-dimensional T2*-weighted Gradient-Echo (T2*w-GRE), in patients undergoing routine brain MRI at 1.5 T.

METHODS: In this study, 172 patients undergoing 1.5 T brain MRI were scanned with a more commonly used susceptibility sequence (standard SWI or T2*w-GRE) and a highly accelerated Wave-SWI sequence. Two radiologists blinded to the acquisition technique scored each sequence for visualization of pathology, motion and signal dropout artifacts, image noise, visualization of normal anatomy (vessels and basal ganglia mineralization), and overall diagnostic quality. Superiority testing was performed to compare Wave-SWI to T2*w-GRE, and non-inferiority testing with 15% margin was performed to compare Wave-SWI to standard SWI.

RESULTS: Wave-SWI performed superior in terms of visualization of pathology, signal dropout artifacts, visualization of normal anatomy, and overall image quality when compared to T2*w-GRE (all p < 0.001). Wave-SWI was non-inferior to standard SWI for visualization of normal anatomy and pathology, signal dropout artifacts, and overall image quality (all p < 0.001). Wave-SWI was superior to standard SWI for motion artifact (p < 0.001), while both conventional susceptibility sequences were superior to Wave-SWI for image noise (p < 0.001).

CONCLUSIONS: Wave-SWI can be performed in a 1.5 T clinical setting with robust performance and preservation of diagnostic quality.

KEY POINTS: • Wave-SWI accelerated the acquisition of 3D high-resolution susceptibility images in 70% of the acquisition time of the conventional T2*GRE. • Wave-SWI performed superior to T2*w-GRE for visualization of pathology, signal dropout artifacts, and overall diagnostic image quality. • Wave-SWI was noninferior to standard SWI for visualization of normal anatomy and pathology, signal dropout artifacts, and overall diagnostic image quality.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Conklin, Figueiro Longo, Tabari, et al. Clinical validation of Wave-CAIPI susceptibility-weighted imaging for routine brain MRI at 1.5 T. Eur Radiol. 2022. PMID: 35925387. doi:10.1007/s00330-022-08871-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。